• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

点石成金:受 COVID-19 大流行启发的颠覆性风湿病学研究平台描述。

Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic.

机构信息

Department of Rheumatology, Amsterdam Rheumatology and Immunology Center, location Reade, Dr. Jan van Breemenstraat 2, 1056 AB, Amsterdam, the Netherlands.

Department of Medical Microbiology and Infection Prevention, Amsterdam UMC, location AMC, 1105 AZ, Amsterdam, the Netherlands.

出版信息

Arthritis Res Ther. 2021 Aug 5;23(1):207. doi: 10.1186/s13075-021-02574-z.

DOI:10.1186/s13075-021-02574-z
PMID:34348783
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8338203/
Abstract

Clinical research projects often use traditional methods in which data collection and signing informed consent forms rely on patients' visits to the research institutes. However, during challenging times when the medical community is in dire need of information, such as the current COVID-19 pandemic, it becomes more urgent to use digital platforms that can rapidly collect data on large numbers of patients. In the current manuscript, we describe a novel digital rheumatology research platform, consisting of almost 5000 patients with autoimmune diseases and healthy controls, that was set up rapidly during the COVID-19 pandemic, but which is sustainable for the future. Using this platform, uniform patient data can be collected via questionnaires and stored in a single database readily available for analysis. In addition, the platform facilitates two-way communication between patients and researchers, so patients become true research partners. Furthermore, blood collection via a finger prick for routine and specific laboratory measurements has been implemented in this large cohort of patients, which may not only be applicable for research settings but also for clinical care. Finally, we discuss the challenges and potential future applications of our platform, including supplying tailored information to selected patient groups and facilitation of patient recruitment for clinical trials.

摘要

临床研究项目通常采用传统方法,其中数据收集和签署知情同意书依赖于患者到研究机构的就诊。然而,在当前的 COVID-19 大流行期间,医疗界急需信息的艰难时期,更需要使用能够快速收集大量患者数据的数字平台。在本手稿中,我们描述了一个新的数字风湿病学研究平台,该平台由近 5000 名自身免疫性疾病患者和健康对照者组成,该平台是在 COVID-19 大流行期间迅速建立的,但未来仍可持续发展。使用该平台,可以通过问卷收集统一的患者数据,并存储在一个便于分析的单一数据库中。此外,该平台还促进了患者和研究人员之间的双向沟通,使患者成为真正的研究合作伙伴。此外,已经在这个大型患者队列中实施了通过指尖采血进行常规和特定实验室检测,这不仅适用于研究环境,也适用于临床护理。最后,我们讨论了我们平台的挑战和潜在的未来应用,包括向选定的患者群体提供定制信息以及为临床试验促进患者招募。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3252/8340458/3bcea60f64de/13075_2021_2574_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3252/8340458/24a96dd7583c/13075_2021_2574_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3252/8340458/3bcea60f64de/13075_2021_2574_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3252/8340458/24a96dd7583c/13075_2021_2574_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3252/8340458/3bcea60f64de/13075_2021_2574_Fig2_HTML.jpg

相似文献

1
Spinning straw into gold: description of a disruptive rheumatology research platform inspired by the COVID-19 pandemic.点石成金:受 COVID-19 大流行启发的颠覆性风湿病学研究平台描述。
Arthritis Res Ther. 2021 Aug 5;23(1):207. doi: 10.1186/s13075-021-02574-z.
2
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology.从患者角度出发探讨家庭指端采血检测对补充和促进风湿病学大型研究的可行性。
RMD Open. 2024 Apr 19;10(2):e003933. doi: 10.1136/rmdopen-2023-003933.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Digital crowdsourcing: unleashing its power in rheumatology.数字众包:在风湿病学中的应用。
Ann Rheum Dis. 2020 Sep;79(9):1139-1140. doi: 10.1136/annrheumdis-2020-217697. Epub 2020 Jun 11.
5
#Covid4Rheum: an analytical twitter study in the time of the COVID-19 pandemic.Covid4Rheum:COVID-19 大流行时期的推特分析研究。
Rheumatol Int. 2020 Dec;40(12):2031-2037. doi: 10.1007/s00296-020-04710-5. Epub 2020 Sep 29.
6
The COVID-19 Global Rheumatology Alliance: evaluating the rapid design and implementation of an international registry against best practice.COVID-19 全球风湿病联盟:评估针对最佳实践的国际注册快速设计和实施。
Rheumatology (Oxford). 2021 Jan 5;60(1):353-358. doi: 10.1093/rheumatology/keaa483.
7
[Annual meeting of the German Society for Rheumatology going virtual-successfully defying the pandemic].[德国风湿病学会年会改为线上举行——成功战胜疫情]
Z Rheumatol. 2021 Jun;80(5):399-407. doi: 10.1007/s00393-021-00997-2. Epub 2021 Apr 20.
8
Impact of COVID-19 on rheumatology practice in the UK-a pan-regional rheumatology survey.新冠疫情对英国风湿病实践的影响-一项泛地区风湿病调查。
Clin Rheumatol. 2021 Jun;40(6):2499-2504. doi: 10.1007/s10067-021-05601-1. Epub 2021 Jan 25.
9
Enhancing rheumatology education during the COVID-19 pandemic.加强 COVID-19 大流行期间的风湿病学教育。
Rheumatol Int. 2021 Mar;41(3):503-508. doi: 10.1007/s00296-020-04769-0. Epub 2021 Jan 27.
10
Clinical outcomes of Covid-19 in patients with rheumatic diseases and the effects of the pandemic on rheumatology outpatient care: A single-centre experience from Turkey.土耳其单中心研究:风湿性疾病患者感染 COVID-19 的临床转归及大流行对风湿科门诊护理的影响。
Int J Clin Pract. 2021 Sep;75(9):e14442. doi: 10.1111/ijcp.14442. Epub 2021 Jun 27.

引用本文的文献

1
Reference intervals of work ability and productivity loss and their use in patients with inflammatory rheumatic and musculoskeletal diseases.工作能力和生产力损失的参考区间及其在炎性风湿性和肌肉骨骼疾病患者中的应用。
RMD Open. 2025 Jan 6;11(1):e004877. doi: 10.1136/rmdopen-2024-004877.
2
Patient-perspective and feasibility of home finger-prick testing to complement and facilitate large-scale research in rheumatology.从患者角度出发探讨家庭指端采血检测对补充和促进风湿病学大型研究的可行性。
RMD Open. 2024 Apr 19;10(2):e003933. doi: 10.1136/rmdopen-2023-003933.
3
Work participation and the COVID-19 pandemic: an observational study in people with inflammatory rheumatic diseases and population controls.

本文引用的文献

1
Perspective of patients with autoimmune diseases on COVID-19 vaccination.自身免疫性疾病患者对新冠病毒疫苗接种的看法。
Lancet Rheumatol. 2021 Apr;3(4):e241-e243. doi: 10.1016/S2665-9913(21)00037-0. Epub 2021 Feb 22.
2
Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry.在 COVID-19 大流行期间,炎症性风湿病患者的自我保护策略和健康行为:丹麦 DANBIO 注册中心随访的 12000 多名炎症性风湿病患者的结果和预测因素。
RMD Open. 2021 Jan;7(1). doi: 10.1136/rmdopen-2020-001505.
3
工作参与度与新冠疫情:一项针对炎症性风湿疾病患者及人群对照的观察性研究
Rheumatol Adv Pract. 2024 Mar 9;8(2):rkae026. doi: 10.1093/rap/rkae026. eCollection 2024.
4
Post-COVID condition in patients with inflammatory rheumatic diseases: a prospective cohort study in the Netherlands.炎症性风湿疾病患者的新冠后状况:荷兰的一项前瞻性队列研究
Lancet Rheumatol. 2023 Jul;5(7):e375-e385. doi: 10.1016/S2665-9913(23)00127-3. Epub 2023 May 31.
5
The impact of the COVID-19 pandemic on ICU clinical trials: a description of one research team's experience.COVID-19 大流行对 ICU 临床试验的影响:一个研究团队经验的描述。
Trials. 2023 May 11;24(1):321. doi: 10.1186/s13063-023-07355-4.
6
EULAR study group on 'MHC-I-opathy': identifying disease-overarching mechanisms across disciplines and borders.EULAR 研究小组关于“MHC-I 病”:在学科和边界内识别疾病普遍存在的机制。
Ann Rheum Dis. 2023 Jul;82(7):887-896. doi: 10.1136/ard-2022-222852. Epub 2023 Mar 27.
7
Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies.使用免疫抑制剂的免疫介导炎症性疾病的接种疫苗患者中出现的德尔塔(B.1.617.2)变异株导致的严重急性呼吸综合征冠状病毒2突破性感染:两项前瞻性队列研究的子研究
Lancet Rheumatol. 2022 Jun;4(6):e417-e429. doi: 10.1016/S2665-9913(22)00102-3. Epub 2022 Apr 29.
8
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study.风湿免疫性炎症性疾病未免疫患者 COVID-19 的抗体产生和疾病严重程度:来自前瞻性队列研究的数据。
RMD Open. 2022 Apr;8(1). doi: 10.1136/rmdopen-2021-002035.
9
COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases.免疫介导的炎症性风湿病患者对COVID-19疫苗的接受情况随时间的变化
Lancet Rheumatol. 2022 May;4(5):e310-e313. doi: 10.1016/S2665-9913(22)00009-1. Epub 2022 Feb 8.
Development of a SARS-CoV-2 Total Antibody Assay and the Dynamics of Antibody Response over Time in Hospitalized and Nonhospitalized Patients with COVID-19.
新型冠状病毒 2 总抗体检测方法的建立及住院和非住院 COVID-19 患者抗体反应随时间的动态变化。
J Immunol. 2020 Dec 15;205(12):3491-3499. doi: 10.4049/jimmunol.2000767. Epub 2020 Oct 30.
4
Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population.患有风湿性疾病的患者比普通人群更严格地遵守新冠疫情隔离措施。
Lancet Rheumatol. 2020 Oct;2(10):e583-e585. doi: 10.1016/S2665-9913(20)30286-1. Epub 2020 Aug 27.
5
The COVID-19 Global Rheumatology Alliance: collecting data in a pandemic.COVID-19 全球风湿病联盟:大流行期间的数据收集。
Nat Rev Rheumatol. 2020 Jun;16(6):293-294. doi: 10.1038/s41584-020-0418-0.
6
Room for improvement in clinical trials for rare diseases.罕见病临床试验仍有改进空间。
Nat Rev Rheumatol. 2020 Mar;16(3):131-132. doi: 10.1038/s41584-020-0376-6.
7
Patients with Rheumatoid Arthritis Acquire Sustainable Skills for Home Monitoring: A Prospective Dual-country Cohort Study (ELECTOR Clinical Trial I).类风湿关节炎患者获得可持续的家庭监测技能:一项前瞻性的中瑞队列研究(ELECTOR 临床试验 I)。
J Rheumatol. 2020 May 1;47(5):658-667. doi: 10.3899/jrheum.181362. Epub 2019 Aug 15.
8
The role of near-patient coeliac serology testing in the follow-up of patients with coeliac disease.近患者乳糜泻血清学检测在乳糜泻患者随访中的作用。
Frontline Gastroenterol. 2014 Jan;5(1):20-25. doi: 10.1136/flgastro-2013-100342. Epub 2013 Sep 3.
9
Dried blood spots from finger prick facilitate therapeutic drug monitoring of adalimumab and anti-adalimumab in patients with inflammatory diseases.指尖采干血斑有助于炎症性疾病患者阿达木单抗及其抗体的治疗药物监测。
Br J Clin Pharmacol. 2017 Nov;83(11):2474-2484. doi: 10.1111/bcp.13371. Epub 2017 Aug 22.
10
How to monitor safety and efficacy of biologic treatment in rare, therapy-refractory immune-mediated inflammatory diseases?如何监测罕见的、治疗难治性免疫介导炎症性疾病中生物治疗的安全性和有效性?
Rheumatology (Oxford). 2018 Apr 1;57(4):591-593. doi: 10.1093/rheumatology/kex016.